Troy– Author –

Chemistry Today Portugal Overview Hovione has launched the world's first next-generation ConsiGma® CDC Flex continuous tableting system at its U.S. facility in New Jersey. This investment establishes a seamless continuous flow pathway fr...

The Pharma Letter USA Overview NorthStar Medical Technologies became the industry's first to commercially produce carrier-free Actinium-225 (Ac-225) using electron accelerator technology in January 2026. In April of the same year, the FD...

NextGen Biologics USA Overview The July 2026 FDA approvals of two distinct oral GLP-1 receptor agonists, oral semaglutide and orforglipron, signify a regulatory inflection point in manufacturing modalities. Differences in their productio...

Daiichi Sankyo Japan Overview Enhertu® (trastuzumab deruxtecan), the HER2-targeted antibody-drug conjugate (ADC) co-developed by Daiichi Sankyo and AstraZeneca, has been approved in China for adjuvant treatment of HER2-positive early bre...

Pharmacally USA Overview Regeneron Pharmaceuticals announced initial clinical results for its investigational MUC16×CD3 bispecific antibody, Ubamatamab, in patients with advanced low-grade serous ovarian cancer (LGSOC). Data from the ong...

Daiichi Sankyo Japan Overview Datroway® (datopotamab deruxtecan), a TROP2-directed DXd antibody-drug conjugate (ADC) co-developed by Daiichi Sankyo and AstraZeneca, has been approved in China for adult patients with unresectable or metas...

Frontiers International Overview This research introduces the 'GrowGen' framework, combining a decoder-only Transformer with reinforcement learning for stable, property-conditioned molecular generation. GrowGen uniquely features property...

Bioengineer.org Switzerland Overview A research team from ETH Zurich and Roche Pharma Research and Early Development has unveiled a closed-loop workflow that predicts chemical reactions with high accuracy, even with limited experimental ...

Oncopeptides AB (publ) Sweden Overview Oncopeptides AB confirmed that its peptide-drug conjugate (PDC) platform successfully penetrates the blood-brain barrier (BBB) and delivers cytotoxic payloads directly into brain tumor cells, based ...

News-Medical USA Overview Researchers at Georgia Tech and Emory University have developed a groundbreaking lipid nanoparticle (LNP) formulation that enables precise targeting of specific regions within the gastrointestinal (GI) tract. Th...